首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3448篇
  免费   257篇
  国内免费   8篇
耳鼻咽喉   41篇
儿科学   67篇
妇产科学   77篇
基础医学   402篇
口腔科学   81篇
临床医学   397篇
内科学   642篇
皮肤病学   61篇
神经病学   277篇
特种医学   90篇
外科学   408篇
综合类   50篇
一般理论   13篇
预防医学   460篇
眼科学   48篇
药学   344篇
中国医学   10篇
肿瘤学   245篇
  2023年   22篇
  2022年   16篇
  2021年   82篇
  2020年   79篇
  2019年   103篇
  2018年   105篇
  2017年   89篇
  2016年   113篇
  2015年   94篇
  2014年   126篇
  2013年   209篇
  2012年   264篇
  2011年   326篇
  2010年   173篇
  2009年   154篇
  2008年   252篇
  2007年   264篇
  2006年   246篇
  2005年   227篇
  2004年   178篇
  2003年   181篇
  2002年   171篇
  2001年   39篇
  2000年   19篇
  1999年   18篇
  1998年   23篇
  1997年   12篇
  1996年   6篇
  1995年   9篇
  1994年   5篇
  1993年   9篇
  1992年   6篇
  1991年   7篇
  1990年   10篇
  1989年   7篇
  1988年   3篇
  1987年   4篇
  1986年   4篇
  1985年   6篇
  1984年   4篇
  1983年   4篇
  1978年   5篇
  1977年   6篇
  1975年   3篇
  1974年   3篇
  1970年   2篇
  1968年   2篇
  1967年   3篇
  1966年   2篇
  1965年   2篇
排序方式: 共有3713条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Infection is one of the leading causes of mortality in dialysis patients, second only to cardiovascular disease. This retrospective study assessed the efficacy and clinical outcomes of influenza vaccination among hemodialysis (HD) patients. In the 2014–2015 season, 104 of 164 (63.6%) HD patients were vaccinated for influenza by the outpatient community health system facilities. Significantly more patients, 159 of 170 (93.8%), were vaccinated in 2015–2016 by the hospital dialysis unit staff during an inpatient HD session (P <0.001). A trend toward fewer complications from influenza infection was observed in vaccinated patients. Among HD patients with diabetes (who comprised 56% of the study population), the incidence of influenza was 17% among nonvaccinated patients vs. 6.3% among those who were vaccinated (P =0.026). The inpatient vaccination policy resulted in a greater rate of vaccination. HD patients with diabetes benefit from influenza vaccination, with a significantly lower incidence of influenza infection.  相似文献   
6.
7.
Triple-negative breast cancer (TNBCs) is a very aggressive and lethal form of breast cancer with no effective targeted therapy. Neoadjuvant chemotherapies and radiotherapy remains a mainstay of treatment with only 25–30% of TNBC patients responding. Thus, there is an unmet clinical need to develop novel therapeutic strategies for TNBCs. TNBC cells have increased intracellular oxidative stress and suppressed glutathione, a major antioxidant system, but still, are protected against higher oxidative stress. We screened a panel of antioxidant genes using the TCGA and METABRIC databases and found that expression of the thioredoxin pathway genes is significantly upregulated in TNBC patients compared to non-TNBC patients and is correlated with adverse survival outcomes. Treatment with auranofin (AF), an FDA-approved thioredoxin reductase inhibitor caused specific cell death and impaired the growth of TNBC cells grown as spheroids. Furthermore, AF treatment exerted a significant in vivo antitumor activity in multiple TNBC models including the syngeneic 4T1.2 model, MDA-MB-231 xenograft and patient-derived tumor xenograft by inhibiting thioredoxin redox activity. We, for the first time, showed that AF increased CD8+Ve T-cell tumor infiltration in vivo and upregulated immune checkpoint PD-L1 expression in an ERK1/2-MYC-dependent manner. Moreover, combination of AF with anti-PD-L1 antibody synergistically impaired the growth of 4T1.2 primary tumors. Our data provide a novel therapeutic strategy using AF in combination with anti-PD-L1 antibody that warrants further clinical investigation for TNBC patients.  相似文献   
8.

We evaluated the long-term serological follow-up of patients with vascular risk factors for chronic Q fever that were previously Coxiella burnetii seropositive. C. burnetii phase I IgG titers were reevaluated in patients that gave informed consent or retrospectively collected in patients already deceased or lost to follow-up. Of 107 patients, 25 (23.4%) became seronegative, 77 (72.0%) retained a profile of past resolved Q fever infection, and five (4.7%) developed chronic Q fever. We urge clinicians to stay vigilant for chronic Q fever beyond two years after primary infection and perform serological testing based on clinical presentation.

  相似文献   
9.
10.
ObjectivesThis study aimed to investigate whether supplementation with 12 mg?day?1 astaxanthin for 7 days can improve exercise performance and metabolism during a 40 km cycling time trial.DesignA randomised, double-blind, crossover design was employed.MethodsTwelve recreationally trained male cyclists (VO2peak: 56.5 ± 5.5  mL?kg?1?min?1, Wmax: 346.8 ± 38.4  W) were recruited. Prior to each experimental trial, participants were supplemented with either 12 mg?day?1 astaxanthin or an appearance-matched placebo for 7 days (separated by 14 days of washout). On day 7 of supplementation, participants completed a 40 km cycling time trial on a cycle ergometer, with indices of exercise metabolism measured throughout.ResultsTime to complete the 40 km cycling time trial was improved by 1.2 ± 1.7% following astaxanthin supplementation, from 70.76 ± 3.93 min in the placebo condition to 69.90 ± 3.78 min in the astaxanthin condition (mean improvement = 51 ± 71 s, p = 0.029, g = 0.21). Whole-body fat oxidation rates were also greater (+0.09 ± 0.13 g?min?1, p = 0.044, g = 0.52), and the respiratory exchange ratio lower (?0.03 ± 0.04, p = 0.024, g = 0.60) between 39–40 km in the astaxanthin condition.ConclusionsSupplementation with 12 mg?day?1 astaxanthin for 7 days provided an ergogenic benefit to 40 km cycling time trial performance in recreationally trained male cyclists and enhanced whole-body fat oxidation rates in the final stages of this endurance-type performance event.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号